Winnergy Medical (Thailand) Performance
WINMED Stock | THB 1.86 0.02 1.09% |
The firm maintains a market beta of -0.26, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Winnergy Medical are expected to decrease at a much lower rate. During the bear market, Winnergy Medical is likely to outperform the market. At this point, Winnergy Medical Public has a negative expected return of -0.0042%. Please make sure to check out Winnergy Medical's semi variance, and the relationship between the maximum drawdown and accumulation distribution , to decide if Winnergy Medical Public performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Winnergy Medical Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Winnergy Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Begin Period Cash Flow | 8.3 M | |
Total Cashflows From Investing Activities | -136.5 M |
Winnergy |
Winnergy Medical Relative Risk vs. Return Landscape
If you would invest 189.00 in Winnergy Medical Public on August 30, 2024 and sell it today you would lose (3.00) from holding Winnergy Medical Public or give up 1.59% of portfolio value over 90 days. Winnergy Medical Public is generating negative expected returns and assumes 2.0941% volatility on return distribution over the 90 days horizon. Simply put, 18% of stocks are less volatile than Winnergy, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Winnergy Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Winnergy Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Winnergy Medical Public, and traders can use it to determine the average amount a Winnergy Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.002
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | WINMED |
Estimated Market Risk
2.09 actual daily | 18 82% of assets are more volatile |
Expected Return
0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Winnergy Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Winnergy Medical by adding Winnergy Medical to a well-diversified portfolio.
Winnergy Medical Fundamentals Growth
Winnergy Stock prices reflect investors' perceptions of the future prospects and financial health of Winnergy Medical, and Winnergy Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Winnergy Stock performance.
Return On Equity | 0.12 | |||
Return On Asset | 0.0444 | |||
Profit Margin | 0.09 % | |||
Operating Margin | 0.08 % | |||
Current Valuation | 1.84 B | |||
Shares Outstanding | 400 M | |||
Price To Earning | 23.63 X | |||
Price To Book | 3.02 X | |||
Price To Sales | 2.50 X | |||
Revenue | 538.7 M | |||
EBITDA | 110.74 M | |||
Cash And Equivalents | 151.3 M | |||
Cash Per Share | 0.38 X | |||
Total Debt | 64.38 M | |||
Debt To Equity | 0.12 % | |||
Book Value Per Share | 1.44 X | |||
Cash Flow From Operations | 90.78 M | |||
Earnings Per Share | 0.16 X | |||
Total Asset | 755.46 M | |||
About Winnergy Medical Performance
By analyzing Winnergy Medical's fundamental ratios, stakeholders can gain valuable insights into Winnergy Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Winnergy Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Winnergy Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Winnergy Medical Public Company Limited imports and distributes medical and diagnostic products in China. Winnergy Medical Public Company Limited was founded in 2004 and is headquartered in Bangkok, Thailand. WINNERGY MEDICAL operates under Medical Distribution classification in Thailand and is traded on Stock Exchange of Thailand.Things to note about Winnergy Medical Public performance evaluation
Checking the ongoing alerts about Winnergy Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Winnergy Medical Public help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Winnergy Medical generated a negative expected return over the last 90 days | |
Winnergy Medical may become a speculative penny stock | |
About 74.0% of the company outstanding shares are owned by insiders |
- Analyzing Winnergy Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Winnergy Medical's stock is overvalued or undervalued compared to its peers.
- Examining Winnergy Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Winnergy Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Winnergy Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Winnergy Medical's stock. These opinions can provide insight into Winnergy Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Winnergy Stock analysis
When running Winnergy Medical's price analysis, check to measure Winnergy Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Winnergy Medical is operating at the current time. Most of Winnergy Medical's value examination focuses on studying past and present price action to predict the probability of Winnergy Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Winnergy Medical's price. Additionally, you may evaluate how the addition of Winnergy Medical to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |